Background: Nanoparticles have emerged as a viable biological candidate with the possibility to be employed as drug carriers. They acquire high surface-to-volume ratios and unique physicochemical features such as biochemical, magnetic, optical, and electrical changes at the cellular, atomic, and molecular levels. This phenomenon has proven extensive utility for biomedical applications, as their biological activity has fewer adverse effects than traditional medications. Main body of the The new spectrum of nanomaterials—nanomedicines—has accomplished disease management by detecting, restoring, and regeneration of damaged tissues. Therefore, designing appropriate nanomaterial-based drug delivery systems for final clinical evaluations requires accurate knowledge of pharmacokinetic factors relevant to the LADME in order to meet the required criteria (liberation, adsorption, distribution, metabolism, and elimination). To identify and predict the in vivo reaction of nanoparticles, a deeper understanding of the link between the physicochemical properties of nanomaterials and their contact with the body is necessary. This will allow a distinguished comparison of traditional medicines and nanoparticles. Short conclusion: This review paper attempts to analyze the basic pharmacokinetic potential of nanoparticles in depth. Therefore, profiling the pharmacokinetic analysis will enable us to review the treatment outcome to overcome their adverse properties, provide a broad overview, and deliver remarkable ways to advance the use of nanoparticles in the biomedical industry. Graphical
Zinc oxide (ZnO) nanoparticles (NPs) are important materials when making different products like sun screens, textiles, and paints. In the current study, the photocatalytic effect of prepared ZnO NPs from Moringa oleifera (M. oleifera) was evaluated on degradation of crystal violet (CV) dye, which is largely released from textile industries and is harmful to the environment. Preliminarily, ZnO NP formation was confirmed using a double beam ultraviolet visible (UV-Vis) spectrophotometer; further, the NP size was estimated using XRD analysis and the functional group analysis was determined using Fourier transform infrared (FT-IR) spectroscopy. The morphology of the synthesized NPs was found to be a hexagonal shape using SEM and TEM analysis and elemental screening was analyzed using EDX. ZnO NPs were shown sized 40–45 nm and spherical in shape. The degradation percentage of ZnO NPs was calculated as 94% at 70 min and the rate of the reaction –k = 0.0282. The synthesized ZnO NPs were determined for effectiveness on biological activities such as antifungal, hemolytic, and antibacterial activity. ZnO NPs showed good antifungal activity against Alternaria saloni and Sclerrotium rolfii strains. Further, we have determined the hemolytic and antibacterial activity of ZnO NPs and we got successive results in antibacterial and hemolytic activities.
20 November 2014 in Applied Biochemistry and Biotechnology
Plants have gained importance in situ bioremediation of heavy metals. In the present study, different concentrations of zinc (Zn2+) (0.5, 5, 10, 15, 20 mg/l) and lead (Pb2+) (1, 2, 4, 6, 8 mg/l) were used to evaluate metal tolerance level of Lemna minor. L.minor were exposed to metals for 4 days and tested for its dry to fresh weight ratio (DW/FW), photosynthetic pigments production and protein content. The oxidative damage was detected by measuring catalase activity. L.minor showed tolerance against Zn2+ and Pb2+ at a concentration of 10 and 4 mg/l, respectively. Among the metals, Pb2+ showed a significant toxicity at 8 mg/l. High concentration (20 mg/l of Zn2+ and 8 mg/l of Pb2+) of the metals displayed a considerable negative effect on soluble proteins (13 fold decrease with Zn2+ and 4 fold decrease with Pb2+) and photosynthetic pigments (twofold decrease with Zn2+ and onefold decrease with Pb2+) and lead to a consequent reduction in number of fronds. Further, the catalase was greatly increased (twofold decrease with Zn2+ and sixfold decrease with Pb2+) under metal stress. The results indicate that L.minor withstands Zn2+ and Pb2+ toxicity up to the concentration of 10 and 4 mg/l, respectively. Hence, the metal tolerant property of this plant shall be exploited for bioremediation of Zinc and Lead in polluted water. Further, the detailed and wide range of heavy metal toxicity studies should be done to reveal the possible use of this plant on large scale bioremediation purpose.
Two edible seaweeds, Sargassum polycystum and Sargassum wightii, were investigated for their antidiabetic potential using in vitro enzyme inhibitory assays. Among the various extracts, petroleum ether and ethyl acetate extracts of S. wightii showed significant inhibitory effects against α-amylase (IC50 378.3 µg/ml) and α-glucosidase (IC50 314.8 µg/ml). Methanol extract of S. wightii showed the highest inhibition against dipeptidyl peptidase-IV (DPP-IV) (IC50 38.27 µg/ml) and moderate antioxidant activity was observed in acetone extract of S. wightii (44%). Similarly, ethyl acetate extract of S. polycystum showed the highest inhibition against α-amylase (IC50 438.5 µg/ml) and methanol extract of S. polycystum showed maximum inhibition against α-glucosidase (IC50 289.7 µg/ml) and DPP-IV (36.94 µg/ml). The antioxidant activity was poor (22%). The extracts were investigated for in vitro cytotoxicity, DNA fragmentation in macrophages and haemolytic activity against erythrocytes, but no notable toxicity was observed with any of the tested extracts. Gas chromatography–mass spectrometry revealed the presence of the antidiabetic compound fucosterol and other major bioactive compounds, giving an insight into the antidiabetic and antioxidant properties of these algae. This study reveals the possible mechanisms of antidiabetic action in vitro, and these two seaweeds may also have an antidiabetic action in vivo.